Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
Transl Psychiatry. 2021 Feb 24;11(1):142. doi: 10.1038/s41398-020-01145-1.
Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a fine-scale ROH analysis using 10 independent cohorts of European ancestry (11,919 AD cases and 9181 controls.) We detected an increase of homozygosity in AD cases compared to controls [β (CI 95%) = 0.070 (0.037-0.104); P = 3.91 × 10; β (CI95%) = 0.043 (0.009-0.076); P = 0.013]. ROHs increasing the risk of AD (OR > 1) were significantly overrepresented compared to ROHs increasing protection (p < 2.20 × 10). A significant ROH association with AD risk was detected upstream the HS3ST1 locus (chr4:11,189,482‒11,305,456), (β (CI 95%) = 1.09 (0.48 ‒ 1.48), p value = 9.03 × 10), previously related to AD. Next, to search for recessive candidate variants in ROHs, we constructed a homozygosity map of inbred AD cases extracted from an outbred population and explored ROH regions in whole-exome sequencing data (N = 1449). We detected a candidate marker, rs117458494, mapped in the SPON1 locus, which has been previously associated with amyloid metabolism. Here, we provide a research framework to look for recessive variants in AD using outbred populations. Our results showed that AD cases have enriched homozygosity, suggesting that recessive effects may explain a proportion of AD heritability.
长段纯合性 (ROH) 是纯合基因型的连续延伸,这是近亲繁殖和隐性遗传的痕迹。阿尔茨海默病 (AD) 中存在隐性基因座的说法;然而,迄今为止,对其搜索评估效果较差。为了研究 AD 中的纯合性,我们在这里使用 10 个独立的欧洲血统队列 (11919 例 AD 病例和 9181 例对照) 进行了精细的 ROH 分析。与对照组相比,AD 病例的纯合性增加[β(95%CI)=0.070(0.037-0.104);P=3.91×10 -5 ;β(95%CI)=0.043(0.009-0.076);P=0.013]。与增加 AD 保护作用的 ROH 相比,增加 AD 风险的 ROH 显著过量(OR >1)(p <2.20×10 -5 )。在 HS3ST1 基因座 (chr4:11,189,482-11,305,456) 上游检测到与 AD 风险显著相关的 ROH (β(95%CI)=1.09(0.48-1.48),p 值=9.03×10 -5 ),先前与 AD 相关。接下来,为了在 ROH 中寻找隐性候选变异,我们从一个杂交群体中提取了同系 AD 病例的同型性图谱,并探索了全外显子组测序数据中的 ROH 区域 (N=1449)。我们检测到一个候选标记 rs117458494,位于 SPON1 基因座,该基因座先前与淀粉样蛋白代谢有关。在这里,我们提供了一个使用杂交群体寻找 AD 隐性变异的研究框架。我们的结果表明,AD 病例的同型性增加,表明隐性效应可能解释了 AD 遗传的一部分。